Filing Details
- Accession Number:
- 0001562180-19-005990
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-10 20:04:39
- Reporting Period:
- 2019-12-09
- Accepted Time:
- 2019-12-10 20:04:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1597553 | Sage Therapeutics Inc. | SAGE | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1042021 | M Jeffrey Jonas | C/O Sage Therapeutics, Inc. 215 First Street Cambridge MA 02142 | President & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-12-09 | 7,500 | $64.20 | 54,530 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $63.88 USD to $64.49 USD. The price reported above reflects the weighted average sale price. The issuer hereby undertakes to provide, upon request, to the SEC staff or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.